Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.150
+0.140 (4.65%)
Jan 17, 2025, 4:00 PM EST - Market closed
Neuphoria Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 17, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.96 | |
| Asset Turnover | - | - | - | 0.10 | 0.02 | 0.07 | |
| Quick Ratio | 3.21 | 3.33 | 4.57 | 12.02 | 12.55 | 0.91 | |
| Current Ratio | 3.30 | 3.45 | 4.87 | 12.46 | 13.10 | 1.01 | |
| Return on Equity (ROE) | -55.39% | -78.44% | -71.40% | -41.64% | -28.86% | -39.88% | |
| Return on Assets (ROA) | - | -39.58% | -37.41% | -18.40% | -14.48% | -10.62% | |
| Return on Capital (ROIC) | -50.11% | -55.49% | -44.40% | -20.74% | -17.50% | -15.67% | |
| Buyback Yield / Dilution | -41.23% | -22.39% | -8.53% | -73.52% | -43.14% | -4.52% | |
| Total Shareholder Return | -41.23% | -22.39% | -8.53% | -73.52% | -43.14% | -4.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.